TheraRadar
← Back
Data updated: Mar 29, 2026

INWOOD LABS

CardiovascularNeurologyGastroenterology
Generics

INWOOD LABS is a generic drug manufacturer focused on Cardiovascular, Neurology, Gastroenterology.

1971
Since
14
Drugs
-
Trials
170
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

PROPRANOLOL HYDROCHLORIDE 2026-01-27
CARBAMAZEPINE 2026-01-05
Labeling
PREDNISONE 2025-10-01
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE 2025-09-19
Manufacturing (CMC)
CARBAMAZEPINE 2025-08-15
Labeling
CARBAMAZEPINE 2025-07-25
METHYLTESTOSTERONE 2025-07-11
Labeling
METHYLTESTOSTERONE 2025-07-11
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 40%
2 drugs
Neurology 40%
2 drugs
Gastroenterology 20%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

VALIDUS PHARMS specialty
Cardiovascular, Gastroenterology, Neurology
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology
Bristol-Myers Squibb big-pharma
Gastroenterology, Neurology
BAUSCH specialty
Cardiovascular, Gastroenterology
Takeda big-pharma
Gastroenterology, Neurology